ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

BCAS2 Human (A60195)

This product is discontinued

BCAS2 Human (A60195) has been discontinued and is no longer available.

View all available products.

Name
BCAS2 Human
Description
Breast Carcinoma Amplified Sequence 2 Human Recombinant
Source
Escherichia Coli.
Sequence
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSMAGT GLVAGEVVVD ALPYFDQGYE APGVREAAAA LVEEETRRYR PTKNYLSYLT APDYSAFETD IMRNEFERLA ARQPIELLSM KRYELPAPSS GQKNDITAWQ ECVNNSMAQL EHQAVRIENL ELMSQHGCNA WKVYNENLVH MIEHAQKELQ KLRKHIQDLN WQRKNMQLTA GSKLREMESN WVSLVSKNYE IERTIVQLEN EIYQIKQQHG EANKENIRQD F.
Purity
Greater than 85.0% as determined by SDS-PAGE.
Product Form
Sterile Filtered colorless solution.
Formulation
The BCAS2 solution (0.25 mg/ml) contains 20mM Tris-HCl buffer (pH 8.0), 20% glycerol, 5mM DTT and 0.2M NaCl.
Storage
Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.
Synonyms
Breast carcinoma-amplified sequence 2, DAM1, DNA amplified in mammary carcinoma 1 protein, Pre-mRNA-splicing factor SPF27, Spliceosome-associated protein SPF 27
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Proteins predicted to interact with BCAS2

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
99.7% Relevancy Score
99.6% Relevancy Score
99.5% Relevancy Score
99.4% Relevancy Score